home / stock / kpti / kpti quote
Last: | $5 |
---|---|
Change Percent: | 0.21% |
Open: | $4.8 |
Close: | $5 |
High: | $5.14 |
Low: | $4.61 |
Volume: | 77,071 |
Last Trade Date Time: | 07/10/2025 03:39:03 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5 | $4.8 | $5 | $5.14 | $4.61 | 77,071 | 07-10-2025 |
$4.81 | $4.71 | $4.81 | $4.81 | $4.66 | 43,426 | 07-09-2025 |
$4.65 | $4.27 | $4.65 | $4.8 | $4.24 | 177,730 | 07-08-2025 |
$4.23 | $4.39 | $4.23 | $4.7 | $4.23 | 63,700 | 07-07-2025 |
$4.39 | $4.69 | $4.39 | $4.83 | $4.39 | 36,017 | 07-04-2025 |
$4.39 | $4.69 | $4.39 | $4.83 | $4.39 | 36,017 | 07-03-2025 |
$4.61 | $4.37 | $4.61 | $4.85 | $4.3 | 112,664 | 07-02-2025 |
$4.36 | $4.34 | $4.36 | $4.48 | $4.25 | 34,694 | 07-01-2025 |
$4.31 | $4.39 | $4.31 | $4.415 | $4.25 | 75,084 | 06-30-2025 |
$4.39 | $4.33 | $4.39 | $4.64 | $4.26 | 32,788 | 06-27-2025 |
$4.49 | $4.56 | $4.49 | $4.5648 | $4.34 | 38,342 | 06-26-2025 |
$4.49 | $4.6 | $4.49 | $4.6662 | $4.34 | 37,953 | 06-25-2025 |
$4.65 | $4.37 | $4.65 | $4.65 | $4.3 | 45,978 | 06-24-2025 |
$4.33 | $4.41 | $4.33 | $4.4196 | $4.12 | 36,013 | 06-23-2025 |
$4.38 | $4.56 | $4.38 | $4.56 | $4.2701 | 23,673 | 06-20-2025 |
$4.44 | $4.36 | $4.44 | $4.59 | $4.32 | 34,355 | 06-19-2025 |
$4.44 | $4.36 | $4.44 | $4.59 | $4.32 | 34,355 | 06-18-2025 |
$4.365 | $4.53 | $4.365 | $4.62 | $4.32 | 31,990 | 06-17-2025 |
$4.54 | $4.47 | $4.54 | $4.55 | $4.3 | 27,371 | 06-16-2025 |
$4.39 | $4.22 | $4.39 | $4.53 | $4.22 | 33,244 | 06-13-2025 |
News, Short Squeeze, Breakout and More Instantly...
Karyopharm Therapeutics Inc. Company Name:
KPTI Stock Symbol:
NASDAQ Market:
0.21% G/L:
$5 Last:
77,071 Volume:
$4.80 Open:
$5 Close:
Karyopharm Therapeutics Inc. Website:
Karyopharm to Present at the Jefferies Global Healthcare Conference PR Newswire NEWTON, Mass. , June 3, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced ...
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEWTON, Mass. , June 2, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapie...
Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference PR Newswire NEWTON, Mass. , May 19, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapie...